2023-2025 We are pleased to share the 2023–2025 ISPE Strategic Plan video, which reflects an ongoing commitment to our mission and vision and outlines our priorities for the next three years. Hear from ISPE International...
This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply chain...
Today, and every day, ISPE Women in Pharma community is working to create a more inclusive pharmaceutical industry. Equal opportunity for equal effort remains the goal for ISPE’s Women in Pharma initiative, with women and...
In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before. Recent advancements...
In 2023, the global ISPE community, with over 21,000 members from 120 countries, redefined excellence in the pharmaceutical industry. As innovators, creators, mentors, and mentees, you shaped the future, celebrating...
Thank you to all those who attended the 2023 ISPE Annual Meeting & Expo, and a big thank you to the sponsors for making this conference possible, and the program committee for curating an in-depth and interactive experience...
ISPE unveiled the prestigious 2023 Facility of the Year Award (FOYA) Overall Winner recipient during the FOYA Celebratory Reception and Banquet at the 2023 ISPE Annual Meeting & Expo. The event showcased the overall winner...
Takeda is a global values-based, R&D-driven biopharmaceutical leader committed to creating better health for people and a brighter future for the world. For more than 240 years, Takeda has focused on delivering transformative...
Nexus Pharmaceuticals, Inc. is a woman-led, minority-owned, and family-owned healthcare company and certified diverse supplier based in Lincolnshire, Illinois, USA. Nexus is a uniquely American family company, built on the...
Join ISPE's thriving community of pharmaceutical science, engineering, and technology professionals to gain fresh perspectives, international insights, and technical expertise through virtual and in-person engagement. Become...
A member of the Roche group since 2009, Genentech discovers, develops, manufactures, and commercializes medicines for people with serious or life-threatening diseases. Their approach to the facility, flexibility of the...
Chugai Pharmaceutical Building 48, known as FJ2, is an API facility for the manufacture of small and mid-size molecule drugs to be used for clinical development purposes. Located in the heart of Japan at a key transportation...
WuXi Biologics in Dundalk, Ireland, is contract research development and manufacturing (CRDMO) facility using hybrid, single-use, scale-out production technology for multiproduct mAb and recombinant protein drug substance...
Introducing the Future of ISPE Guidance Documents At ISPE, our mission has always been to connect knowledge, operational excellence and regulatory insights. In keeping with this commitment, we are excited to announce that we...
The SERUM’s NISHWAS project is recognized with the FOYA 2023 in the category “Supply Chain”, as it exemplifies how to deliver in a record time a large pharmaceutical manufacturing capability and capacity in condition of...